Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis

NCT03672292 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment took longer than anticipated (slow enrollment during COVID).

Conditions

Invasive Pulmonary Aspergillosis

Interventions

DRUG: SCY-078
DRUG: Voriconazole
OTHER: Oral Placebo Tablets

Sponsor

Scynexis, Inc.